A B HT29 HCT15 Colo205 Ls174T LS180 Isotypic control

Slides:



Advertisements
Similar presentations
Vascular smooth muscle refers to the particular type of smooth muscle found within, and composing the majority of the wall of blood vessels. (Wikipedia)smooth.
Advertisements

Supplementary Figure S1
SIRTs inhibitor: Sirtinol Supplementary Figure S3A Supplementary Figure S3 Sirtinol but not EX527 or PDF-170 significantly enhances ithe cytotoxic and.
Supplementary Figure S1 FPKM ESRP1ESRP2 normaltumor Supplementary Figure S1. ESRP1 and ESRP2 mRNA expression in 65 normal kidney samples and 474 ccRCC.
ShCon shNaa10p GAPDH MCL1 EPHB4 RPS6KA5 SMAD1 BFAR EIF4B CYR61 STAT5B NFkbil2 VEGFC TNFRSF1A CyclinD Supplementary Figure S1 RKO cells A B siCon siNaa10p-395siNaa10p-464siNaa10p-649.
Supplementary Figure S4
Volume 141, Issue 5, Pages e1 (November 2011)
Supplemental Figure 2 A B vehicle
500 mg total protein /mL S-CM 250 mg total protein /mL S-CM
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 41, Issue 2, Pages (August 2004)
Volume 141, Issue 5, Pages e1 (November 2011)
Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.
FL cells are dependent on BCL6 in a NOTCH2-dependent manner.
Identifying Inhibitors of Epithelial-Mesenchymal Transition by Connectivity Map–Based Systems Approach  Ajaya Kumar Reka, PhD, Rork Kuick, MS, Himabindu.
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
Difucosylated oligosaccharide Lewis Y is contained within integrin αvβ3 on RL95-2 cells and required for endometrial receptivity  Dongmei Zhang, Ph.D.,
Supplementary Figure S2
FLAG β-actin p53 SET M.w. kDa D β-actin p53 G9a
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 126, Issue 1, Pages (January 2004)
Volume 84, Issue 1, Pages (July 2013)
IL-22 Increases the Innate Immunity of Tissues
Volume 54, Issue 6, Pages (June 2014)
Molecular Therapy - Nucleic Acids
Supplementary Figure S1: FGFR4 silencing synergistically enhances the effects of chemotherapy in colon cancer cells. siFGFR4 FGFR4_6 FGFR4_2 Neg Con FGFR4.
Andreea M. Bujor, Jaspreet Pannu, Shizhong Bu, Edwin A. Smith, Robin C
Volume 142, Issue 3, Pages e2 (March 2012)
Volume 46, Issue 5, Pages (June 2012)
Integrin α5β1 Activates the NLRP3 Inflammasome by Direct Interaction with a Bacterial Surface Protein  Hye-Kyoung Jun, Sung-Hoon Lee, Hae-Ri Lee, Bong-Kyu.
Transforming growth factor (TGF)-β1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation.
Volume 2, Issue 2, Pages (August 2012)
Eun-Joo Kim, Jeong-Hoon Kho, Moo-Rim Kang, Soo-Jong Um  Molecular Cell 
Volume 133, Issue 4, Pages (October 2007)
Volume 68, Issue 1, Pages (July 2005)
Supplementary 3 PTB PTB Actin Actin GM1953 control 0.03
Microarray analysis of phospho-Twist1–responsive genes.
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 16, Issue 6, Pages (June 2015)
Supplementary Figure 1 HCT116 MOLT4
Detailed analysis of post‐translational compensation of varying Erk concentration. Detailed analysis of post‐translational compensation of varying Erk.
14-3-3ζ Turns TGF-β to the Dark Side
The TGF-β pathway is activated in the skin after C
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Supplementary Figure 1. A
Supplementary Figure 1 IP: IgG HA 3HA-E2F1: cIAP1: wt K
Overexpression of CD109 in the Epidermis Differentially Regulates ALK1 Versus ALK5 Signaling and Modulates Extracellular Matrix Synthesis in the Skin 
mRNA level as % relative to
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Supplementary Figure S4
Volume 48, Issue 4, Pages e6 (April 2018)
Supplementary Fig. S1 BCL2 5’flanking ctrl siRNA luc
TNF-α Suppresses α-Smooth Muscle Actin Expression in Human Dermal Fibroblasts: An Implication for Abnormal Wound Healing  Mytien T. Goldberg, Yuan-Ping.
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Volume 16, Issue 1, Pages (July 2014)
Involvement of αvβ5 Integrin in the Establishment of Autocrine TGF-β Signaling in Dermal Fibroblasts Derived from Localized Scleroderma  Yoshihide Asano,
Collagen Synthesis Is Suppressed in Dermal Fibroblasts by the Human Antimicrobial Peptide LL-37  Hyun Jeong Park, Dae Ho Cho, Hee Jung Kim, Jun Young.
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 32, Issue 2, Pages (February 2010)
Supplementary Figure 1 A B C SW620 HT29 SW620
TGFBRAP1 plays a critical role in CHIT1 augmentation of TGF-β1 signaling and TGFβR expression. TGFBRAP1 plays a critical role in CHIT1 augmentation of.
Volume 12, Issue 1, Pages (January 2019)
Volume 2, Issue 2, Pages (August 2012)
(fold of TGF-β1 response)
Volume 63, Issue 1, Pages (July 2016)
Volume 26, Issue 3, Pages (March 2007)
A B D C E F Supplementary Figure S4. Epping et al. IP: flag input IgG
Polyamine concentration (nmol/mg protein)
Supplementary Figure 3. Characteristics of cryopreserved NK cells with or without incubation and/or IL-2 stimulation after thawing. The cell number (A),
The Kinases MEKK2 and MEKK3 Regulate Transforming Growth Factor-β-Mediated Helper T Cell Differentiation  Xing Chang, Fang Liu, Xiaofang Wang, Aiping.
Presentation transcript:

A B HT29 HCT15 Colo205 Ls174T LS180 Isotypic control concentration (IU/ml/106 cells) 7.6% 0.8% 95.3% 26.3% 42.2% CA19-9 Cell number FITC FUT3 FUT6 HT29 HCT15 Colo205 Ls174T LS180 C Isotypic control Relative expression ( / ß-actin) 50.2% 0.7% 99.83% 57.4% 88.7% sLex Cell number FITC Supplementary Figure 1. CA19-9 and sLex expression correlated with FUT3 and FUT6

Supplementary Figure 2. Suppression of FUT3 and/or FUT6 by siRNAs siFUT3 + siFUT6 Colo205 LS174T No treat Random siFUT3 FUT3 1.0 0.94 0.23 0.22 ß-actin siFUT3 + siFUT6 No treat Random siFUT6 FUT6 1.0 1.02 0.28 0.30 ß-actin Supplementary Figure 2. Suppression of FUT3 and/or FUT6 by siRNAs

A random siRNA1 siRNA2 FUT1 1.0 0.26 0.28 FUT2 1.0 0.36 0.32 FUT4 1.0 0.21 0.22 FUT5 1.0 0.44 0.72 FUT7 1.0 0.33 0.43 FUT8 1.0 0.27 0.35 B NT Random siFUT1 siFUT2 siFUT4 siFUT5 siFUT7 siFUT8 pSmad2 1.0 1.36 1.0 1.25 1.0 3.17 1.0 1.38 1.0 1.33 1.0 1.42 1.0 1.52 1.0 1.35 Smad2 TGF-β – + – + – + – + – + – + – + – + Supplementary Figure 3. Suppression of FUT3 and FUT6 inhibits Smad2 phosphorylation upon TGF-ß stimulation

TGF-β (hr) IgG 6 12 TßR-I IP / AAL IB TßR-I 1.00 1.05 1.04 TßR-I IP / TßRI IB TßR-I Supplementary Figure 4. Fucosylation of TßR-I was not affected by TGF-ß stimulation

siFUT3 + 6 Random siFUT3 siFUT6 NT TßR-I IP / CA19-9 IB 1.00 1.05 0.35 0.25 0.29 siFUT3 + 6 Random siFUT3 siFUT6 NT TßR-I IP / sLex IB 1.00 0.93 0.34 0.23 0.16 Supplementary Figure 5. TßRs bound-CA19-9 and sLex inhibited by siFUT3 and/or siFUT6